[1]PD-1/PD-L1抑制剂在妇科肿瘤的研究进展 [2]免疫检查点抑制剂治疗非小细胞肺癌耐药机制研究进展 [3]Ongoing clinical trials of PD-1 and PD-L1 inhibitors for lung cancer in China [4]中国非小细胞肺癌免疫检查点抑制剂治疗专家共识(2019年版） [5]PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective Study [6]T3011疱疹病毒注射液联合PD-1/PD-L1抑制剂治疗晚期实体瘤的Ib / IIa期临床研究 [7]Phase II study of enlonstobart (SG001), a novel PD-1 inhibitor in patients with PD-L1 positive recurrent/metastatic cervical cancer [8]Ⅰ期临床试验的规范化管理 [9]一项在不适用PD-1/PD-L1抑制剂治疗的局部复发无法手术或转移性三阴性乳腺癌患者中比较Dato-DXd与研究者所选化疗的研究 [10]SRCA肿瘤药物敏感试验前瞻性临床研究